Fertility preservation in female classic galactosemia patients

被引:0
作者
Britt van Erven
Cynthia S Gubbels
Ron J van Golde
Gerard A Dunselman
Josien G Derhaag
Guido de Wert
Joep P Geraedts
Annet M Bosch
Eileen P Treacy
Corrine K Welt
Gerard T Berry
M Estela Rubio-Gozalbo
机构
[1] Maastricht University Medical Center,Department of Pediatrics and Department of Genetic Metabolic Diseases Laboratory
[2] Maastricht University,GROW, Research school for Oncology and Developmental Biology
[3] Maastricht University Medical Center,Department of Clinical Genetics
[4] Harvard Medical School,Currently: The Manton Center for Orphan Disease Research, Division of Genetics, Boston Children’s Hospital
[5] Maastricht University Medical Center,Department of Obstetrics and Gynecology
[6] Maastricht University,Department of Health, Ethics & Society
[7] Department of Pediatrics,National Centre for Inherited Metabolic Disorders
[8] Academic Medical Center,undefined
[9] Children’s University Hospital,undefined
[10] Reproductive Endocrine Unit,undefined
[11] Massachusetts General Hospital,undefined
[12] Harvard Medical School,undefined
[13] The Manton Center for Orphan Disease Research,undefined
[14] Division of Genetics,undefined
[15] Boston Children’s Hospital,undefined
[16] Harvard Medical School,undefined
来源
Orphanet Journal of Rare Diseases | / 8卷
关键词
Classic galactosemia; GALT deficiency; Primary ovarian insufficiency; POI; Fertility preservation; Cryopreservation;
D O I
暂无
中图分类号
学科分类号
摘要
Almost every female classic galactosemia patient develops primary ovarian insufficiency (POI) as a diet-independent complication of the disease. This is a major concern for patients and their parents, and physicians are often asked about possible options to preserve fertility. Unfortunately, there are no recommendations on fertility preservation in this group. The unique pathophysiology of classic galactosemia with a severely reduced follicle pool at an early age requires an adjusted approach. In this article recommendations for physicians based on current knowledge concerning galactosemia and fertility preservation are made. Fertility preservation is only likely to be successful in very young prepubertal patients. In this group, cryopreservation of ovarian tissue is currently the only available technique. However, this technique is not ready for clinical application, it is considered experimental and reduces the ovarian reserve. Fertility preservation at an early age also raises ethical questions that should be taken into account. In addition, spontaneous conception despite POI is well described in classic galactosemia. The uncertainty surrounding fertility preservation and the significant chance of spontaneous pregnancy warrant counseling towards conservative application of these techniques. We propose that fertility preservation should only be offered with appropriate institutional research ethics approval to classic galactosemia girls at a young prepubertal age.
引用
收藏
相关论文
共 336 条
[1]  
Fridovich-Keil JL(2011)Ovarian function in girls and women with GALT-deficiency galactosemia J Inherit Metab Dis 34 357-366
[2]  
Gubbels CS(2012)Classical Galactosaemia in Ireland: incidence, complications and outcomes of treatment J Inherit Metab Dis 36 21-27
[3]  
Spencer JB(2011)Introduction to the Maastricht workshop: lessons from the past and new directions in galactosemia J Inherit Metab Dis 34 249-255
[4]  
Sanders RD(2004)Living with classical galactosemia: health-related quality of life consequences Pediatrics 113 e423-e428
[5]  
Land JA(2003)A strategy for fertility services for survivors of childhood cancer Hum Fertil (Camb) 6 A1-A39
[6]  
Rubio-Gozalbo E(2005)Fertility preservation and reproduction in cancer patients Fertil Steril 83 1622-1628
[7]  
Coss KP(2006)American Society of Clinical Oncology: American Society of Clinical Oncology recommendations on fertility preservation in cancer patients J Clin Oncol 24 2917-2931
[8]  
Doran PP(2009)Preservation of fertility in patients with cancer N Engl J Med 360 902-911
[9]  
Owoeye C(2012)Adolescent and young adult oncology. Clinical practice guidelines in oncology J Natl Compr Canc Netw 10 1112-1150
[10]  
Codd MB(2008)[National guideline ’Cryopreservation of ovarian tissue’] Ned Tijdschr Geneeskd 152 2452-2455